Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy

Clinical trial NCT04923594 · COMPLETED

Trial details

NCT number: NCT04923594
Sponsor: NLS Pharmaceutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Narcolepsy Excessive Daytime Sleepiness Cataplexy Narcolepsy

Start date: 2021-09-13
Primary completion: 2022-06-30
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.